ClinicalTrials.gov
public full text
Public Domain
Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder
The aim of this study is to test if combining the antidepressant Citalopram with Pentoxifylline (PTX), a medicine with anti-inflammatory and phosphodiesterase inhibitory properties, enhanced antidepressant efficacy in adult patients with major depressive disorder (MDD) when compared to Citalopram alone.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.#871304
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder#981439
- Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation#864966
- Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine#914027
- Double-Blind Treatment of Major Depressive Disorder With Vilazodone#860276
Record · ID 908251
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive